Last reviewed · How we verify
NCT03981562
Vitamin D and Hereditary Haemorrhagic Telangiectasia
Phase 2 trial testing Vit D in Hereditary Haemorrhagic Telangiectasia in 60 participants. Status unknown.
1 July 2020
Quick facts
| Lead sponsor | St. Paul's Hospital, Canada |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 16 July 2018 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 September 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Vit D — full drug profile →
- Placebo Oral Tablet — full drug profile →
Conditions studied
- Hereditary Haemorrhagic Telangiectasia — all drugs for Hereditary Haemorrhagic Telangiectasia →
Sponsor
St. Paul's Hospital, Canada
Who can join
19 and older, any sex, with Hereditary Haemorrhagic Telangiectasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to assess whether supplementing vitamin D in patients diagnosed with Hereditary Haemorrhagic Telangiectasia (HHT) will decrease the frequency and severity of nosebleeds these patients experience. It is hypothesized that the larger the dose of daily vitamin D given to the patients, the less frequent and less severe the nosebleeds will be.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding.
Albiñana V, Cuesta AM, Rojas-P I, Gallardo-Vara E, et al · · 2020 · cited 20× · PMID 32517280 · DOI 10.3390/jcm9061766
Verify or expand the search:
- PubMed search for NCT03981562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vit D
Trials testing the same drug.
- NCT06458686 — Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitam · Phase 1, PHASE2 · not yet recruiting
- NCT06962761 — the Effect of Use of Vit d and Probiotic as a Supplementaition in the Treatment of Bronchial Asthma in Patient Aged 6 to · completed
- NCT05486715 — Vitamin d Level and it's Association With Disease Activity in Egyptian Rheumatoid Arthritis Patients · unknown
- NCT04459247 — Short Term, High Dose Vitamin D Supplementation for COVID-19 · NA · completed
- NCT05167617 — Vitamin D Improves Clinical Manifestations in Asthmatic Children · Phase 1 · completed
Other recruiting trials for Hereditary Haemorrhagic Telangiectasia
Currently open trials in the same condition.
- NCT07414446 — Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device · NA · recruiting
- NCT07111598 — Immunological Effects of Iron Supplementation in HHT Disease · NA · recruiting
- NCT03841422 — Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHT · active not recruiting
Other St. Paul's Hospital, Canada trials
Trials by the same sponsor.
- NCT06750302 — Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial · Phase 1, PHASE2 · recruiting
- NCT06570590 — Prospective Study of Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities · NA · not yet recruiting
- NCT05006287 — The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery · Phase 2 · active not recruiting
- NCT04476628 — Efficacy of Budesonide Via Delayed Release vs Immediate Release · EARLY_PHASE1 · withdrawn
- NCT04449965 — Povidone-Iodine Rinses in the Management of COVID-19 · EARLY_PHASE1 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03981562 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Paul's Hospital, Canada
- Last refreshed: 11 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03981562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing